SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Clarification sought from Sun Pharmaceutical Industries Ltd
The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd with respect to news article appearing on www.ndtv.com April 27, 2021, titled "Merck Taps 5 Indian Drugmakers To Expand Covid Drug Production".The reply is awaited.
Sun Pharma breakout can take stock up 20%
Sun shares have risen 11.8 per cent in less than a month. The stock is well placed above its 20, 50, 100- and 200-day moving averages, suggesting a bullish trend. The run-up in the stock price along with volume suggest a rally in the offing, said technical analysts. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Shareholding for the Period Ended March 31, 2021
Sun Pharmaceutical Industries Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here Sun Pharmaceutical Industries Ltd - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 17, 2021 for Shanghvi Finance Pvt Ltd Sun Pharmaceutical Industries Ltd - 524715 - Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ashok BhutaDesignation :- Any Other SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed intimation of Loss of share certificates/issue of duplicate share certificates
Sun Pharma Q4 PAT seen up 82.2% YoY to Rs. 1,462.7 cr: Sharekhan
Net Sales are expected to increase by 6.2 percent Y-o-Y (down 1.6 percent Q-o-Q) to Rs. 8,692.6 crore, according to Sharekhan.
Remdesivir shortage in Nagpur; Nitin Gadkari dials Sun Pharma chief
Union minister Nitin Gadkari has called up Sun Pharma's chief to arrange for 10,000 injections of Remdesivir in Nagpur in view of a shortage of the medicine here in MaharashtraSun Pharma: Why bull-call spread trade is the right strategy this week
Sell the 660-strike call and simultaneously buy the 640-strike call Sun Pharmaceutical Industries Ltd - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015